Mouse model for ablation of proliferating microgliain acute CNS injuries
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Activation of microglia, the primary immune effectors of the CNS and proinflammatory signaling, is a hallmark of brain damage. However, it remains controversial whether microglial cells have beneficial or detrimental functions in various neuropathological conditions. We report the generation of transgenic mice that express a mutant form of herpes simplex virus type 1 thymidine kinase (HSV‐1 TK mt‐30) driven by the myeloid‐specific CD11b promoter. Using two paradigms of nervous system damage, hypoglossal nerve axotomy, and cortical stab injury, we show that specific ablation of proliferating microglia in CD11b‐TK mt‐30 mice can be achieved by administration of ganciclovir. For example, after hypoglossal nerve injury, a 75% reduction in proliferating microglial cells was observed at the site of injury. The CD11b‐TK mt‐30 transgenic mouse should provide a valuable tool for studying the role of microglia in CNS damage and repair. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235 · cited 1×
“Evidence indicates that activation of microglia, the main mediators of innate immunity in the CNS, can have either beneficial or detrimental effects (Nguyen et al., 2002; Wyss-Coray and Mucke, 2002).”
BackgroundMICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 4×
“Alternatively the generation of chimeric transgenic mice through bone marrow transplant from WT donor mice can be used to limit unwanted toxicity (Heppner et al., 2005).”
BackgroundInfluentialHuitinga, I., van Rooijen, N., de Groot, C. J., Uitdehaag, B. M., & Dijkstra, C. D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1025 · Cited by 506 · cited 2×
“…as liposomes do not cross the intact blood brain barrier and intraventricular injection of clodronate liposomes results in depletion of paraventricular macrophages and meningeal macrophages but does not reduce the microglial cell population (Huitinga et al., 1990; Polfliet et al., 2001a,b, 2002).”
BackgroundBone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity
Vallières, L., & Sawchenko, P. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05197.2003 · Cited by 245
Self-citationIntracerebroventricular injection of microglia protects against focal brain ischemia
Kitamura, Y., Takata, K., Inden, M., Tsuchiya, D., Yanagisawa, D., Nakata, J., & Taniguchi, T. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.94.203 · Cited by 104
Cited by
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Self-citationSelective Ablation of Proliferating Microglial Cells Exacerbates Ischemic Injury in the Brain
Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y. C., & Kriz, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5360-06.2007 · Cited by 874
Self-citationRegulation of innate immune responses in the brain
Rivest, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2565 · Cited by 843
Glial Cells and Their Function in the Adult Brain: A Journey through the History of Their Ablation
Jäkel, S., & Dimou, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00024 · Cited by 500
Microglial Activation in Traumatic Brain Injury
Donat, C. K., Scott, G., Gentleman, S. M., & Sastre, M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00208 · Cited by 480
Proliferating resident microglia after focal cerebral ischaemia in mice
Denes, A., Vidyasagar, R., Feng, J., Narvainen, J., McColl, B. W., Kauppinen, R. A., & Allan, S. M. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600495 · Cited by 342
“It is known that microglia can enter the cell cycle and exert proliferating activity in the brain on various challenges, such as acute brain injury (Gowing et al, 2006; Ladeby et al, 2005) and global cerebral ischaemia (Liu et al, 2001).”
BackgroundIRF8 Is a Critical Transcription Factor for Transforming Microglia into a Reactive Phenotype
Masuda, T., Tsuda, M., Yoshinaga, R., Tozaki-Saitoh, H., Ozato, K., Tamura, T., & Inoue, K. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.02.014 · Cited by 338
Microglia: gatekeepers of central nervous system immunology
Tambuyzer, B. R., Ponsaerts, P., & Nouwen, E. J. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0608385 · Cited by 331
To Kill a Microglia: A Case for CSF1R Inhibitors
Green, K. N., Crapser, J. D., & Hohsfield, L. A. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.07.001 · Cited by 262
Lalancette-Hébert, M., Swarup, V., Beaulieu, J. M., Bohacek, I., Abdelhamid, E., Weng, Y. C., Sato, S., & Kriz, J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1498-12.2012 · Cited by 251
“By using a CD11bTK mouse model in which we selectively ablated the population of proliferating microglial cells by ganciclovir, we observed that a great majority of the proliferating resident microglial cells coexpress Mac2/galectin-3 and insulin-like growth factor-1 (IGF-1) (Gowing et al., 2006; Lalancette-Hébert et…”
BackgroundMethodRequirement of Myeloid Cells for Axon Regeneration
Barrette, B., Hébert, M.-A., Filali, M., Lafortune, K., Vallières, N., Gowing, G., Julien, J.-P., & Lacroix, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1447-08.2008 · Cited by 244
“This method has been used with great success by our laboratories in previous studies in which we reported the expression of cytokines/ growth factors in models of CNS diseases and injuries (Gowing et al., 2006b; Boivin et al., 2007).”
MethodSelf-citationSuh, H.-S., Zhao, M.-L., Derico, L., Choi, N., & Lee, S. C. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-37 · Cited by 226
CD11b+Ly6G−myeloid cells mediate mechanical inflammatory pain hypersensitivity
Ghasemlou, N., Chiu, I. M., Julien, J.-P., & Woolf, C. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501372112 · Cited by 188
Self-citationAn updated assessment of microglia depletion: current concepts and future directions
Han, J., Harris, R. A., & Zhang, X.-M. (2017) · Molecular Brain · doi:10.1186/s13041-017-0307-x · Cited by 141
The brain’s best friend: microglial neurotoxicity revisited
Hellwig, S., Heinrich, A., & Biber, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00071 · Cited by 126
Bennett, R. E., & Brody, D. L. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3320 · Cited by 64
Gowing, G., Lalancette-Hébert, M., Audet, J.-N., Dequen, F., & Julien, J.-P. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.021 · Cited by 53
Self-citationKoupourtidou, C., Schwarz, V., Aliee, H., Frerich, S., Fischer-Sternjak, J., Bocchi, R., Simon-Ebert, T., Bai, X., Sirko, S., Kirchhoff, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46625-w · Cited by 48
Metadata
- Authors
- Gowing, G., Vallières, L., & Julien, J.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2005-11-07
- Volume
- 53
- Issue
- 3
- Pages
- 331-337
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2024193688
- Cited by
- 71
- References
- 6
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.